Details of the Drug Combination
General Information of Drug Combination (ID: DC4BELG)
| Drug Combination Name |
SY-1425 Hepzato
|
|||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Indication |
|
|||||||||||||||||
| Component Drugs | SY-1425 | Hepzato | ||||||||||||||||
| N.A. | N.A. | |||||||||||||||||
| High-throughput Screening Result | Testing Cell Line: HT29 | |||||||||||||||||
| Zero Interaction Potency (ZIP) Score: 7.28 | ||||||||||||||||||
| Bliss Independence Score: 9.75 | ||||||||||||||||||
| Loewe Additivity Score: 4.54 | ||||||||||||||||||
| LHighest Single Agent (HSA) Score: 1.51 | ||||||||||||||||||
Molecular Interaction Atlas of This Drug Combination
| Molecular Interaction Atlas (MIA) | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Indication(s) of SY-1425 |
|
|||||||||||||||||||||||||
|
SY-1425 Interacts with 1 DTT Molecule(s)
|
||||||||||||||||||||||||||
| Indication(s) of Hepzato |
|
|||||||||||||||||||||||||
Test Results of This Drug Combination in Other Disease Systems
|
||||||||||||||||||||||||||||||
References
